Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | ACHE | P22303 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5887622 | 0.84 | ACHE (0.43) | TSHRACHEALDH1A1MAOAMAOB | |
| SCHEMBL28270216 | 0.81 | TSHR (0.53) | TSHRACHEALDH1A1MAOAMAOB | |
| SCHEMBL30206994 | 0.81 | TSHR (0.53) | TSHRACHEALDH1A1MAOAMAOB | |
| SCHEMBL28396164 | 0.77 | — | — | |
| O-Xylene SCHEMBL2854068 | 0.71 | — | — | |
| O-Xylene SCHEMBL8216257 | 0.71 | TSHR (1.00) | TSHRACHEALDH1A1CA1CA2 | |
| O-Xylene SCHEMBL11035539 | 0.71 | TSHR (1.00) | TSHRACHEALDH1A1CA1CA2 | |
| O-Xylene SCHEMBL170581 | 0.71 | TSHR (1.00) | TSHRACHEALDH1A1CA1CA2 | |
| O-Xylene SCHEMBL10522915 | 0.71 | TSHR (1.00) | TSHRACHEALDH1A1CA1CA2 | |
| O-Xylene SCHEMBL11034038 | 0.71 | TSHR (1.00) | TSHRACHEALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10337030-B2 | Microbially-mediated method for synthesis of metal chalcogenide nanoparticles | UT-BATTELLE, LLC (US) | 2019-07-02 | — | — | US | disclosed |
| US-9909221-B2 | Controllable reductive method for synthesizing metal-containing particles | UT-BATTELLE, LLC (US) | 2018-03-06 | — | — | US | disclosed |
| US-20180010153-A1 | MICROBIALLY-MEDIATED METHOD FOR SYNTHESIS OF METAL CHALCOGENIDE NANOPARTICLES | U.S. DEPARTMENT OF ENERGY | 2018-01-11 | — | — | US | disclosed |
| US-9768333-B2 | Microbially-mediated method for synthesis of non-oxide semiconductor nanoparticles | UT-BATTELLE, LLC (US) | 2017-09-19 | — | — | US | disclosed |
| US-9637828-B2 | Electrochemical method for synthesizing metal-containing particles and other objects | UT-BATTELLE, LLC (US) | 2017-05-02 | — | — | US | disclosed |
| US-9196760-B2 | Methods for producing complex films, and films produced thereby | UT-BATTELLE, LLC (US) | 2015-11-24 | — | — | US | disclosed |
| WO-2014164954-A1 | ELECTROCHEMICAL METHOD FOR SYNTHESIZING METAL-CONTAINING PARTICLES AND OTHER OBJECTS | UT-BATTELLE, LLC (US) | 2014-10-09 | — | — | WO | disclosed |
| WO-2014164950-A1 | METHOD FOR SYNTHESIZING METAL OXIDE PARTICLES | UT-BATTELLE, LLC (US) | 2014-10-09 | — | — | WO | disclosed |
| WO-2014164953-A1 | CONTROLLABLE REDUCTIVE METHOD FOR SYNTHESIZING METAL-CONTAINING PARTICLES | UT-BATTELLE, LLC (US) | 2014-10-09 | — | — | WO | disclosed |
| US-20140273147-A1 | METHOD FOR SYNTHESIZING METAL OXIDE PARTICLES | OAK RIDGE ASSOCIATED UNIVERSITIES | 2014-09-18 | — | — | US | disclosed |
| US-20040237384-A1 | Fuel compositions exhibiting improved fuel stability | OCTANE INTERNATIONAL, LTD. | 2004-12-02 | — | — | US | disclosed |
| US-20040176336-A1 | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium | RODRIGUEZ GUSTAVO C (US) | 2004-09-09 | — | — | US | disclosed |
| US-20040106587-A1 | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium | NEW LIFE PHARMACEUTICALS INC. | 2004-06-03 | — | — | US | disclosed |
| US-6652608-B1 | Fuel compositions exhibiting improved fuel stability | OCTANE INTERNATIONAL, LTD. | 2003-11-25 | — | — | US | disclosed |
| US-6511970-B1 | Multiphasic hormonal regimen wherein at least one of the daily dosages has at least 0.5 mg of norgestrel and an estrogen component | NEW LIFE PHARMACEUTICALS INC. | 2003-01-28 | — | — | US | disclosed |
| US-20010044431-A1 | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium | NEW LIFE PHARMACEUTICALS INC. | 2001-11-22 | — | — | US | disclosed |
| EP-1051461-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR, William C. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999066009-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR WILLIAM C (US) | 1999-12-23 | — | — | WO | disclosed |
| EP-0954558-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR, William C. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1998026028-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR WILLIAM C (US) | 1998-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106587-A1 | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium | HDGF, PGF, OGFRL1 | TSHR 1759/4885ACHE 2980/4885ALDH1A1 929/4885 |
| US-20010044431-A1 | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium | HDGF, PGF, OGFRL1 | TSHR 1759/4885ACHE 2980/4885ALDH1A1 929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.